Using organoids of the respiratory mucosa, they are testing defined substances for their effectiveness against the proliferation of SARS-CoV-2. They also want to know how the infection with the coronavirus affects the barrier function of the mucus formation of their respiratory tract model.
Source and further information:
https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/corona-wirkstoffe-im-schnelltest/